Market Overview

UPDATE: CVS Caremark, Cardinal Health Announce Creation Of Largest Generic Sourcing Entity In US

Share:
Related CVS
Benzinga's M&A Chatter for Thursday May 21, 2015
Top 10 Most Popular American Stores
3 Consumer ETFs To Gain On CVS Health Buyout (Seeking Alpha)

CVS Caremark (NYSE: CVS) and Cardinal Health (NYSE: CAH) today announced the signing of an agreement to form the largest generic sourcing entity in the U.S., which is the world's largest generic drug market. Both companies are contributing their sourcing and supply chain expertise to this 50/50 joint venture and are committing to source generic drugs through it. The companies separately announced a three-year extension through June 2019 of Cardinal Health's existing pharmaceutical distribution agreements with CVS Caremark. 

The U.S.-based joint venture is expected to be operational as soon as July 1, 2014, and will have an initial term of 10 years. Under this arrangement, the joint venture will source and negotiate generic supply contracts for both Cardinal Health and CVS Caremark.

See full press release

Posted-In: News Guidance Legal Management Global

 

Related Articles (CAH + CVS)

Around the Web, We're Loving...